Benign Prostatic Hyperplasia/Urinary Retention

Mortality Risk Compared Among Men Receiving Drug Therapy for BPH/LUTS

By June 18, 2018

Researchers conducted a retrospective matched cohort study to compare the risk of death among BPH patients treated with 5ARIs, as monotherapy or in combination with alpha-blockers, and those treated with alpha-blockers alone.

AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

By May 18, 2018

"We are confident this guideline is fully aligned with the latest science on treatments for patients with non-metastatic and metastatic CRPC," said Michael Cookson, MD, member of the 2018 amendment panel.

AUA: Guideline on Surgical Management of BPH-Related Lower Urinary Tract Symptoms

By May 17, 2018

The new guideline includes 22 recommendations focused on utilizing common surgical techniques and minimally invasive surgical therapies.

Nymox Plans to Submit NDA for Novel Benign Prostatic Hyperplasia Treatment

By February 07, 2018

Fexapotide triflutate 2.5 mg was found to be safe and effective for long-term treatment of BPH.

Italian-Style Coffee Consumption May Reduce Prostate Cancer Risk

By April 26, 2017

Nearly 7,000 Italian men participating in the Moli-sani epidemiological study aged ≥50 years were monitored for an average of 4.25 years.

USPSTF Drafts Prostate CA Screening Recommendations

By April 11, 2017

The USPSTF performed a systematic review of the existing evidence and concluded that the potential benefits and harms of prostate-specific antigen (PSA)-based screening are "closely balanced" in men aged 55-69 years.

5α-Reductase Inhibitor Use and Suicide Risk Examined in Older Patients

March 27, 2017

No increase in risk of suicide was found but an increased risk of self-harm and depression was noted during initial 18 months after initiation of 5-reductase.

Suicidality, Depression Risk with BPH Drugs Examined

By March 24, 2017

The data showed adult males who used 5 alpha-reductase inhibitors did not exhibit a significantly increased risk of suicide, however the risk of self-harm did increase.

Fexapotide vs. Conventional BPH Treatments Evaluated in Crossover Study

By August 26, 2016

Nymox announced positive data from the Phase 3 study of fexapotide for the treatment of benign prostatic hyperplasia (BPH) and localized prostate cancer.

Mylan Launches Generic Avodart

By June 28, 2016

Mylan announced the launch of Dutasteride Capsules, the generic version of GlaxoSmithKline's Avodart.

Technique Could Help Reduce Nocturia in Benign Prostatic Hyperplasia

April 05, 2016

Prostatic artery embolization (PAE) may help improve nocturia symptoms in men with benign prostatic hyperplasia,

Recommendations for Management of Recurrent UTI in Older Men

February 12, 2016

Case presented of patient with extended-spectrum beta-lactamase E. coli infection

Impact of 2012 USPSTF Guideline Against PSA Screening Explored

December 29, 2015

After, men undergoing prostate needle biopsy more likely to be diagnosed with high-risk disease

PSA Screening May Be Harmful for Patients With ESRD

December 28, 2015

Screening not linked to improved patient survival after transplant; may delay time to listing, transplant

Significant Changes With Sham Sx in Prostatic Hyperplasia

November 18, 2015

Review shows significant change in symptom scores, maximum urinary flow in sham surgery arm

Teva Launches Generic Avodart

By October 13, 2015

Teva announced the launch of Dutasteride Capsules, the generic version of GlaxoSmithKline's Avodart.

Age, Obesity Could Affect Gene Expression in Symptomatic BPH

September 25, 2015

Age and obesity affect gene regulation in men with symptomatic benign prostatic hyperplasia, according to a study published in The Journal of Urology.

Sexual Side Effects of BPH Drugs May Last in Tx

By August 27, 2015

A review in the journal Endocrine Reviews and Metabolic Disorders reports that greater education and awareness of the potential risks associated with two treatments for benign prostate hyperplasia (BPH) is needed among both patients and clinicians, along with additional research exploring these reported adverse effects.

Nocturia, Reassurance Key Drivers for Men Seeking LUTS Care

July 01, 2015

Overall, men with LUTS showed remarkably poor knowledge about their symptoms

Significant ED Worsening Seen With BPH Drug

By June 15, 2015

Men treated for benign prostatic hyperplasia (BPH) with the type II 5 alpha-reductase inhibitor finasteride could be significantly more likely to experience erectile dysfunction (ED) compared to those taking the alpha-1A blocker tamsulosin.

Treating Periodontitis May Help Ease Prostatitis Symptoms

May 26, 2015

Periodontal problems linked to inflammation throughout the body, researcher says

Counterfeit ED Drug Found in U.S. Mail

By January 22, 2015

The Food and Drug Administration (FDA) is warning healthcare professionals and consumers that counterfeit versions of Cialis (tadalafil; Eli Lilly) 20mg tablets were discovered in the mail in transit to a U.S. consumer.

Statins Not Tied to BPH, Sexual Dysfunction in Men

December 10, 2014

Statins do not appear to affect male gonadal and sexual function, according to a new study.

Metabolic Syndrome Tied to LUTS Risk, Severity

December 08, 2014

Metabolic abnormalities such as metabolic syndrome and insulin resistance are associated with lower urinary tract symptoms (LUTS), according to two studies.

Urinary Retention Seen in 5% of Posterior Lumbar Surgeries

November 05, 2014

The risk of developing postoperative urinary retention (POUR) after posterior lumbar spine surgery is approximately 5%, with certain patient factors associated with higher risk.

Adherence to AUA BPH Guidelines Varies

October 21, 2014

Researchers have evaluated urologist adherence to the American Urological Association (AUA) guidelines for the management of benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS).

Can Tamsulosin Improve Urinary Symptoms in Women with Dysfunctional Voiding, Recurrent UTI?

September 09, 2014

Because α1-AR appear to have a role in lower urinary tract function, the use of α1-AR antagonists like tamsulosin may be effective for female patients with dysfunctional voiding.

Is Pumpkin Seed Effective for Lower Urinary Tract Symptoms in Men?

September 05, 2014

Can supplementing with pumpkin seed improve lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)?

Physical Activity, Nocturia Inversely Linked

September 05, 2014

Men who are physically active are less likely to report nocturia, commonly associated with benign prostatic hyperplasia (BPH).

Lasting Drop in Prostate Cancer Death With PSA, Study Confirms

August 07, 2014

Prostate-specific antigen (PSA) screening is associated with a lasting reduction in prostate cancer mortality.